脂酸用于治疗渐进性多发性硬化症:第二阶段随机临床试验
Rebecca I Spain1,2, M Mateo Paz Soldán3,4, Mark S Freedman5
1Department of VA, VA Portland Health Care System, OR.
Neurology
|December 15, 2025
概括
脂酸 (LA) 在24个月内没有改善渐进性多发性硬化症 (PMS) 患者的步行速度或其他临床结果. 虽然大脑缩标志物与LA显示稳定性,但与蛋白尿增加有关,并没有显示整体疗效.
科学领域:
- 神经科学是一个神经科学.
- 临床神经学 临床神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 以前的试点研究表明,脂酸 (LA) 可能通过减少大脑缩来为多发性硬化症 (MS) 提供神经保护.
- 渐进性多发性硬化症 (PMS) 的特点是持续的神经系统衰退,影响移动性和生活质量.
研究的目的:
- 评估口服脂肪酸 (LA) 在患有渐进性多发性硬化症 (PMS) 的患者中保持步行速度的疗效.
- 评估LA对大脑缩和其他PMS临床结果的影响.
- 为了确定LA在这个患者群体中的安全性和耐受性.
主要方法:
- 一个为期24个月的随机,双盲,安慰剂对照试验,涉及118名患有初级或二级PMS的参与者.
- 参与者每天接受1,200毫克口服LA或安慰剂.
- 主要结局是定时25英尺步行速度的变化;次要结局包括脑缩,残疾措施和不良事件.
主要成果:
- 与安慰剂相比,脂酸 (LA) 并没有显著减缓步行速度的下降.
- 在LA和安慰剂组之间的其他临床或患者报告的结果中没有发现显著差异.
- 在LA组中,全脑和深灰质体积似乎稳定,而在安慰剂组中则呈现下降趋势. 在LA群体中,蛋白尿量较高.
结论:
- 口服酸 (LA) 在24个月的时间内没有显示出改善渐进性多发性硬化症 (PMS) 步行速度或其他结果的临床疗效.
- LA与新发现的不良事件有关,包括蛋白尿.
- 可能需要对LA的机制进行进一步的研究,以解释PMS中的体积成像生物标志物.
相关概念视频
Parkinson's Disease: Treatment
940
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
940
Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
459
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
459
Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Clinical Trials: Overview
4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Clinical Trials
10.1K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.1K


